$SNSS Viracta Therapeutics, Inc. Insider Trading Week 32/2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Viracta Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Viracta Therapeutics, Inc. in week 32/2014.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Sell | S | 6.77 | 694 | 4,700 | 4,894,387 | 4.9 M to 4.9 M (-0.01 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Sell | S | 6.77 | 36,406 | 246,531 | 4,895,081 | 4.9 M to 4.9 M (-0.74 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Sell | S | 6.90 | 591 | 4,079 | 4,931,487 | 4.9 M to 4.9 M (-0.01 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Sell | S | 6.90 | 31,009 | 214,024 | 4,932,078 | 5 M to 4.9 M (-0.62 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Sell | S | 6.62 | 12,622 | 83,559 | 4,963,087 | 5 M to 5 M (-0.25 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Sell | S | 6.62 | 662,378 | 4,385,009 | 4,975,709 | 5.6 M to 5 M (-11.75 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | SANDELL SCOTT D | 10% Owner | Sell | S | 6.76 | 35,540 | 240,190 | 4,926,033 | 5 M to 4.9 M (-0.72 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | SANDELL SCOTT D | 10% Owner | Sell | S | 6.62 | 675,000 | 4,468,568 | 4,961,573 | 5.6 M to 5 M (-11.98 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | KOLLURI KRISHNA KITTU | 10% Owner | Sell | S | 6.76 | 35,540 | 240,190 | 4,926,033 | 5 M to 4.9 M (-0.72 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | KOLLURI KRISHNA KITTU | 10% Owner | Sell | S | 6.62 | 675,000 | 4,468,568 | 4,961,573 | 5.6 M to 5 M (-11.98 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | DRANT RYAN D | 10% Owner | Sell | S | 6.76 | 35,540 | 240,190 | 4,926,033 | 5 M to 4.9 M (-0.72 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | DRANT RYAN D | 10% Owner | Sell | S | 6.62 | 675,000 | 4,468,568 | 4,961,573 | 5.6 M to 5 M (-11.98 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | KERINS PATRICK J | 10% Owner | Sell | S | 6.76 | 35,540 | 240,190 | 4,926,033 | 5 M to 4.9 M (-0.72 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | KERINS PATRICK J | 10% Owner | Sell | S | 6.62 | 675,000 | 4,468,568 | 4,961,573 | 5.6 M to 5 M (-11.98 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | BASKETT FOREST | 10% Owner | Sell | S | 6.76 | 35,540 | 240,190 | 4,926,033 | 5 M to 4.9 M (-0.72 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | BASKETT FOREST | 10% Owner | Sell | S | 6.62 | 675,000 | 4,468,568 | 4,961,573 | 5.6 M to 5 M (-11.98 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | BARRIS PETER J | 10% Owner | Sell | S | 6.76 | 35,540 | 240,190 | 4,926,033 | 5 M to 4.9 M (-0.72 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | BARRIS PETER J | 10% Owner | Sell | S | 6.62 | 675,000 | 4,468,568 | 4,961,573 | 5.6 M to 5 M (-11.98 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Sell | S | 6.77 | 694 | 4,700 | 91,495 | 92.2 K to 91.5 K (-0.75 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Sell | S | 6.77 | 36,406 | 246,531 | 4,801,377 | 4.8 M to 4.8 M (-0.75 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Sell | S | 6.90 | 591 | 4,079 | 92,189 | 92.8 K to 92.2 K (-0.64 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Sell | S | 6.90 | 31,009 | 214,024 | 4,837,783 | 4.9 M to 4.8 M (-0.64 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Sell | S | 6.62 | 12,622 | 83,559 | 92,780 | 105.4 K to 92.8 K (-11.98 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Sell | S | 6.62 | 662,378 | 4,385,009 | 4,868,792 | 5.5 M to 4.9 M (-11.98 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | BARRETT M JAMES | 10% Owner | Sell | S | 6.76 | 35,540 | 240,190 | 4,926,033 | 5 M to 4.9 M (-0.72 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | BARRETT M JAMES | 10% Owner | Sell | S | 6.62 | 675,000 | 4,468,568 | 4,961,573 | 5.6 M to 5 M (-11.98 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | Growth Equity Opportunities Fu ... | 10% Owner | Sell | S | 6.76 | 35,540 | 240,190 | 4,926,033 | 5 M to 4.9 M (-0.72 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | Growth Equity Opportunities Fu ... | 10% Owner | Sell | S | 6.62 | 675,000 | 4,468,568 | 4,961,573 | 5.6 M to 5 M (-11.98 %) |